Literature DB >> 35402210

Surgical management in phyllodes tumors of the breast: a systematic review and meta-analysis.

Yufan Wei1,2, Yanying Yu3, Yashuang Ji4, Yuting Zhong2,5, Ningning Min1,2, Huayu Hu1,2, Qingyu Guan1,2, Xiru Li2.   

Abstract

Background: Information is still controversial in the studies regarding the current optimal surgical management of phyllodes tumors (PTs) of the breast. Local recurrence (LR) may occur with an upgraded in the pathological grade, influencing the prognosis of patients with PT. This systematic review and meta-analysis aimed to investigate the association of LR risk with margin status and margin width which could have significant implications on the surgical management of PT.
Methods: Independent and comprehensive searches were performed by two authors through five databases including PubMed, Medline, Embase, ScienceDirect and Cochrane Library from January 1990 to October 2021. Studies investigating the association between margin width, margin status and LR rates were considered for inclusion. Study quality was evaluated using the Newcastle-Ottawa Scale (NOS). Meta-analysis was performed using RevMan5.3 software, and statistical heterogeneity was assessed using the Chi-square test and quantified using the I2 statistic. Visual inspection of funnel plots was used to judge publication bias.
Results: A total of 34 articles were included in this article, all of which with NOS scores above 5. Regardless of the PT grade, positive margin significantly increased the risk of LR [odds ratio (OR) 3.64, 95% confidence interval (CI): 2.60-5.12]. No significant difference was found in the risk of LR between the margins <1 and ≥1 cm (OR 1.39, 95% CI: 0.67-2.92). For benign and borderline PTs, there were no significant differences of the LR risk between breast-conserving surgery (BCS) and mastectomy (benign OR 0.68, 95% CI: 0.12-3.78; borderline OR 1.14, 95% CI: 0.29-4.51). While the LR risk was significantly increased by BCS for malignant PT (OR 2.77, 95% CI: 1.33-5.74). Discussion: Different surgical management strategies should be considered for different PT grades. BCS was a feasible option and margins <1 cm was not significantly associated with LR risk for all grade of PT. After BCS, benign PT with positive margin could adopt the "wait and watch" strategy with regular follow-up, while borderline and malignant PTs were expected to underwent re-excision to ensure negative margins. More studies are still needed to clarify and update the existing conclusions and improve the prognosis of PT patients. 2022 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Phyllodes tumors of the breast; local recurrence (LR); margin; surgical management; systematic review and meta-analysis

Year:  2022        PMID: 35402210      PMCID: PMC8984980          DOI: 10.21037/gs-21-789

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  51 in total

1.  Surgical Margins and Adjuvant Therapies in Malignant Phyllodes Tumors of the Breast: A Multicenter Retrospective Study.

Authors:  Mathias Neron; Christophe Sajous; Simon Thezenas; Sophie Piperno-Neumann; Fabien Reyal; Marick Laé; Camille Chakiba; Audrey Michot; Nicolas Penel; Charles Honoré; Clémentine Owen; François Bertucci; Sébastien Salas; Esma Saada-Bouzid; Thibaud Valentin; Emmanuelle Bompas; Mehdi Brahmi; Isabelle Ray-Coquard; Jean-Yves Blay; Nelly Firmin
Journal:  Ann Surg Oncol       Date:  2020-01-27       Impact factor: 5.344

Review 2.  Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates.

Authors:  Yanhong Zhang; Celina G Kleer
Journal:  Arch Pathol Lab Med       Date:  2016-07       Impact factor: 5.534

3.  Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast.

Authors:  I Kapiris; N Nasiri; R A'Hern; V Healy; G P Gui
Journal:  Eur J Surg Oncol       Date:  2001-12       Impact factor: 4.424

4.  Benign and borderline phyllodes tumors of the breast: Clinicopathologic analysis of 205 cases with emphasis on the surgical margin status and local recurrence rate.

Authors:  Iskender Sinan Genco; Vaishali Purohit; Kayla Hackman; Lisa Ferreira; Bugra Tugertimur; Sabina Hajiyeva
Journal:  Ann Diagn Pathol       Date:  2021-01-22       Impact factor: 2.090

5.  Phyllodes tumor of the breast; a case series.

Authors:  Murat Akin; Oktay Irkorucu; Hande Koksal; Ipek Isik Gonul; Serap Gultekin; Osman Kurukahvecioglu; Ahmet Ziya Anadol; Ercument Tekin
Journal:  Bratisl Lek Listy       Date:  2010       Impact factor: 1.278

6.  Reappraisal of conventional risk stratification for local recurrence based on clinical outcomes in 285 resected phyllodes tumors of the breast.

Authors:  Cha Kyong Yom; Wonshik Han; Sung-Won Kim; So Yeon Park; In Ae Park; Dong-Young Noh
Journal:  Ann Surg Oncol       Date:  2015-02-05       Impact factor: 5.344

Review 7.  Width of margins in phyllodes tumors of the breast: the controversy drags on?-a systematic review and meta-analysis.

Authors:  Arnaud Toussaint; Romain Piaget-Rossel; Coraline Stormacq; Patrice Mathevet; Karine Lepigeon; Patrick Taffé
Journal:  Breast Cancer Res Treat       Date:  2020-09-15       Impact factor: 4.872

8.  Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast.

Authors:  Hassan M Abdalla; Mona A Sakr
Journal:  J Egypt Natl Canc Inst       Date:  2006-06

9.  Association Between Recurrence and Re-Excision for Close and Positive Margins Versus Observation in Patients with Benign Phyllodes Tumors.

Authors:  Tracy-Ann Moo; Hanan Alabdulkareem; Andrew Tam; Constance Fontanet; Yao Lu; Alyssa Landers; Timothy D'Alfonso; Rache Simmons
Journal:  Ann Surg Oncol       Date:  2017-08-01       Impact factor: 5.344

10.  Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center.

Authors:  Jing Wei; Yu-Ting Tan; Yu-Cen Cai; Zhong-Yu Yuan; Dong Yang; Shu-Sen Wang; Rou-Jun Peng; Xiao-Yu Teng; Dong-Geng Liu; Yan-Xia Shi
Journal:  Chin J Cancer       Date:  2014-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.